Researches on Activity of NK cells in Cancer and in Obstetric

Researches on Activity of NK cells in Cancer:

1. Hou H, Mao L, Wang J, Liu W, Lu Y, Yu J, Zhou Y, Mao L, Wang F, Sun Z. Establishing the reference intervals of NK cell functions in healthy adults. Hum Immunol. 2016; 77:637-642
2. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol. 2001; 96:574-578
3. Funa K, Nilsson B, Jacobsson G, Alm GV. Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas. Br J Cancer. 1984; 50:231-233
4. Lee SB, Cha J, Kim IK, Yoon JC, Lee HJ, Park SW, Cho S, Youn DY, Lee H, Lee CH, Lee JM, Lee KY, Kim J. A highthroughput assay of NK cell activity in whole blood and its clinical application. Biochem Biophys Res Commun. 2014; 445:584-590
5. Lee, J., Park, K. H., Ryu, J. H., Bae, H. J., Choi, A., Lee, H., … & Oh, E. J. (2017). Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer. Oncotarget, 8(41), 70431.
6. Koo, K. C. et al. Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer. PLoS ONE. 2013 Nov 4;8(11):e78049
7. Mandal, A., & Viswanathan, C. (2015). Natural killer cells: in health and disease. Hematology/oncology and stem cell therapy, 8(2), 47-55.

Researches on Activity of NK cells in Obstetric:

1. A.L.Veenstra van Nieuwenhoven, The immunology of successful pregnancy. Human Reproduction Update, Vol.9, No.4 pp. 347-357, 2003. DOI: 10.1093/humupd/dmg026
2. Peter Parham. NK Cells and Trophoblasts, DOI: 10.1084/jem.20041783 |Published October 18, 2004
3. Lash, G.E. and Bulmer, J.N. (2011) Do uterine natural killer (uNK) cells contribute to female reproductive disorders? Journal of Reproductive Immunology, 88, 156-164. doi:10.1016/j.jri.2011.01.003
4. Marcio Nogueira Rodrigues et al. Role of natural killer (NK) cells during pregnancy: A review. Vol.3, No.2, 138-144 (2013) Open Journal of Animal Sciences http://dx.doi.org/10.4236/ojas.2013.32021.
5. Moffett-King, A. (2002) Natural killer cells and preg-nancy. Nature Reviews Immunology, 2, 656-663. doi:10.1038/nri886
6. Arcuri, F., Cintorino, M. and Carducci, A. (2006) Human decidual natural killer cells are a source and target of ma- crophage migration inhibitory factor. Reproduction, 131, 175-182. doi:10.1530/rep.1.00857
7. Binqing Fu, Yonggang Zhou, et al. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors. CellPress. 2017, Immunity 47, 1100–1113.
8. Binqing Fu et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal–fetal interface.pnas.org/cgi/doi/10.1073/pnas.1206322110.
9. Paola Vacca et al. Origin, phenotype and function of human natural killer cells in pregnancy. Trends in Immunology November 2011, Vol. 32, No. 11.
10. Huddleston, H. and Schust, D.J. (2004) Immune intera- ctions at the maternal-fetal interface: A focus on antigen presentation. American Journal of Reproduction, 51, 283- 289. doi:10.1111/j.1600-0897.2004.00157.x
11. Hunter, H., Hammer, A., Dohr, G. and Hunt J.S. (1998) HLA expression at the maternal-fetal interface. Clinical and Developmental Immunology, 6, 197-204.
12. King, A., Hilby, S.E., Verma, S., Burrows, T., Gardner, L. and Loke, Y.W. (1997) Uterine NK cells and trophoblast HLA class I molecules. American Journal of Reprodu- ctive Immunology, 37, 459-462. doi:10.1111/j.1600-0897.1997.tb00260.
13. Dahl M, Klitkou L et al. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G. Hum Immunol. 2015 Apr;76(4):260-71. doi: 10.1016/j.humimm.2015.01.015.Epub2015Jan 28.
14. Jassem RM et al. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Hum Immunol. 2012 Aug;73(8):811-7. doi: 10.1016/j.humimm.2012.05.009. Epub 2012 May 28.
15. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991;6:791–8.
16. Yamada H, Morikawa M. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003;50:351–4.
17. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995;345:1340–2.
18. Srividya Seshadri, Sesh Kamal Sunkara. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Human Reproduction Update, Vol.20, No.3 pp. 429–438, 2014.
19. Beer, A.E., Kwak, J.Y. and Ruiz, J.E. (1996) Immunophenotypic pro®les of peripheral blood lymphocytes in women with recurrent pregnancy losses. and in infertile women with multiple failed in vitro fertilization cycles. Am. J. Reprod. Immunol., 35, 376±382.
20. Royal College of Obstetricians and Gynaecologists. The Role of Natural Killer Cells in Human Fertility. Scientific Impact Paper No. 53 December 2016.
21. Michael Krigstein et al. Prednisolone for repeated implantation failure associated with high natural killer cell levels:Case Report and Risk-Benefit analysis. J Obstet Gynaecol. 2012 Aug;32(6):518-9. doi: 10.3109/01443615.2012.693988.
22. Siobhan Quenby et al. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertility and Sterility_ 2005. Vol. 84, No. 4, doi:10.1016/j.fertnstert.2005.05.012.
23. Ai-Wei Tang et al. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Human Reproduction, Vol.28, No.7 pp. 1743–1752, 2013.
24. Mostafa F. Gomaa et al. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double‑blind placebo randomized controlled trial. Gynecologic Endocrinology and Reproductive Medicine. Arch Gynecol Obstet DOI 10.1007/s00404-014-3262-0.\
25. Marwan Alhalabi. Prednisolone improves implantation in ICSI patients with high peripheral CD69 + NK Cells. Human Reproduction 26(1):i219.
26. Gautam N. Allahbadia. Intralipid Infusion is the Current Favorite of Gynecologists for Immunotherapy. The Journal of Obstetrics and Gynecology of India (July–August 2015) 65(4):213–217. DOI 10.1007/s13224-015-0732-7.
27. Manuela Moraru1,Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56+ Cells. American Journal of Reproductive Immunology 68 (2012) 75-84.
28. Perricone et al. IVIg Perricone R, Di Muzio G, Perricone C, Giacomelli R, De Nardo D, Fontana L, et al. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immuno – globulins. Am J Reprod Immunol 2006;55:232–9.